Le Lézard
Classified in: Business
Subject: JOINT VENTURES

RecycLiCo Provides Update on Zenith Transaction 


SURREY, British Columbia, July 12, 2023 (GLOBE NEWSWIRE) -- RecycLiCo Battery Materials Inc. ("RecycLiCo" or the "Company") is pleased to announce that the TSX Venture Exchange (the "Exchange") has provided acceptance of the joint venture agreement (the "Agreement") between the Company and Zenith Chemical Corporation ("Zenith").  

Under the Agreement, RecycLiCo and Zenith will enter into a 50-50 joint venture to build a 2,000 metric ton per year lithium-ion battery recycling plant in Taiwan. The plant, estimated to cost US$25 million, will use RecycLiCo's proprietary process to convert lithium-ion battery waste into lithium-ion battery cathode precursor, lithium hydroxide and other related products.  As consideration for contributing half of the capital required, Zenith will hold a 50% interest in the joint venture. As consideration for contributing 40% of the capital required and granting a license for its technology, RecycLiCo will also hold a 50% in the joint venture.  

As an incentive to enter the joint venture, RecycLiCo will receive a royalty on net product sales for the first eight years, while Zenith will receive 4,000,000 RecycLiCo shares and 6,000,000 share purchase warrants (which will not be exercisable until the 30th day following the date on which construction of the recycling plant is completed). The warrants will have a five-year term, and an exercise price of $0.35 per share. All securities issued under the Agreement will have a four-month hold period. 

About RecycLiCo 

RecycLiCo Battery Materials Inc. is a battery materials company specializing in sustainable lithium-ion battery recycling and materials production. RecycLiCo has developed advanced technologies that efficiently recover battery-grade materials from lithium-ion batteries, addressing the global demand for environmentally friendly solutions in energy storage. With minimal processing steps and up to 99% extraction of lithium, cobalt, nickel, and manganese, the patented, closed-loop hydrometallurgical process turns lithium-ion battery waste into battery-grade cathode precursor, lithium hydroxide, and lithium carbonate for direct integration into the re-manufacturing of new lithium-ion batteries. 

About Zenith 

Zenith Chemical Corporation, a Taiwanese company, specializes in the production of nickel-based chemicals, including high-purity nickel sulfate for lithium-ion batteries. With a strong focus on serving the lithium-ion battery industry, Zenith's products have gained recognition and qualification from major cathode producers worldwide. The company also has a shareholding partnership with Hanwa Co., Ltd, a large publicly traded Japanese distribution company known for its expertise in lithium-ion battery-related materials. Additionally, Zenith collaborates, through a joint venture, with Central Glass Co., Ltd., a leading Japanese publicly traded company specializing in fluorine-based chemicals and cater to the semiconductor and lithium-ion battery markets. 

For more information, please contact: 
Teresa Piorun 
Senior Corporate Secretary 
Telephone: 778-574-4444 
Email: [email protected] 

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release may contain "forward-looking statements", which are statements about the future based on current expectations or beliefs. For this purpose, statements of historical fact may be deemed to be forward-looking statements. Forward?looking statements by their nature involve risks and uncertainties, and there can be no assurance that such statements will prove to be accurate or true. Investors should not place undue reliance on forward-looking statements. The Company does not undertake any obligation to update forward-looking statements except as required by law. 



These press releases may also interest you

at 16:10
Contineum Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with specific clinical impairments for the treatment of...

at 16:10
Despegar.com, Corp. ("Despegar" or the "Company"), Latin America's leading travel technology company, today announced unaudited financial results for the three-months ended March 31, 2024 ("first quarter 2024" or "1Q24"). Financial results are...

at 16:10
Build-A-Bear Workshop, Inc. today announced that the Company will report first quarter fiscal 2024 results for the period ended May 4, 2024, on Thursday, May 30, 2024, prior to the opening of trading on the New York Stock Exchange. The Company will...

at 16:10
Ulta Beauty, Inc. today announced that its financial results for the first quarter of fiscal 2024 will be released Thursday, May 30, 2024, after the market closes. The Company will host a conference call at 4:30 p.m. ET / 3:30 p.m. CT to discuss the...

at 16:10
Take-Two Interactive Software, Inc. today reported results for the fourth quarter and fiscal year 2024, ended March 31, 2024. For further information, please see the fourth quarter and fiscal 2024 results slide deck posted to the Company's investor...

at 16:10
Exicure, Inc. , has historically been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. In September 2022, the Company announced a significant reduction in force,...



News published on and distributed by: